- Home
- FIZZ vs ZLAB Comparison
FIZZ vs ZLAB Comparison
Compare FIZZ & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIZZ
- ZLAB
- Stock Information
- Founded
- FIZZ 1985
- ZLAB 2013
- Country
- FIZZ United States
- ZLAB China
- Employees
- FIZZ N/A
- ZLAB N/A
- Industry
- FIZZ Beverages (Production/Distribution)
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- FIZZ Consumer Staples
- ZLAB Health Care
- Exchange
- FIZZ Nasdaq
- ZLAB Nasdaq
- Market Cap
- FIZZ 3.8B
- ZLAB 3.6B
- IPO Year
- FIZZ 1991
- ZLAB 2017
- Fundamental
- Price
- FIZZ $45.48
- ZLAB $31.19
- Analyst Decision
- FIZZ Strong Sell
- ZLAB Buy
- Analyst Count
- FIZZ 1
- ZLAB 4
- Target Price
- FIZZ $41.00
- ZLAB $47.37
- AVG Volume (30 Days)
- FIZZ 160.7K
- ZLAB 937.3K
- Earning Date
- FIZZ 06-25-2025
- ZLAB 05-08-2025
- Dividend Yield
- FIZZ 7.23%
- ZLAB N/A
- EPS Growth
- FIZZ 9.67
- ZLAB N/A
- EPS
- FIZZ 1.99
- ZLAB N/A
- Revenue
- FIZZ $1,185,040,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- FIZZ $1.96
- ZLAB $44.07
- Revenue Next Year
- FIZZ $2.55
- ZLAB $49.13
- P/E Ratio
- FIZZ $22.79
- ZLAB N/A
- Revenue Growth
- FIZZ 0.34
- ZLAB 43.72
- 52 Week Low
- FIZZ $38.25
- ZLAB $16.01
- 52 Week High
- FIZZ $53.48
- ZLAB $39.77
- Technical
- Relative Strength Index (RSI)
- FIZZ 60.84
- ZLAB 50.80
- Support Level
- FIZZ $43.62
- ZLAB $30.11
- Resistance Level
- FIZZ $45.66
- ZLAB $31.34
- Average True Range (ATR)
- FIZZ 0.89
- ZLAB 1.14
- MACD
- FIZZ 0.03
- ZLAB 0.07
- Stochastic Oscillator
- FIZZ 93.94
- ZLAB 62.48
About FIZZ National Beverage Corp.
National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.